Steven Cohen Pliant Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $51 Billion
- Q3 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 4,338,394 shares of PLRX stock, worth $7.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,338,394Holding current value
$7.51 Million% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
112Shares Held
58.9MCall Options Held
209KPut Options Held
102K-
Tang Capital Management LLC San Diego, CA6MShares$10.4 Million0.4% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.5MShares$7.79 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.51MShares$6.07 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$5.21 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $84.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...